from ischemic stroke by the non-vascular extension of the lesion, but also by progression of the lesion, by hyperperfusion, by reduced oxygen extraction, and by a vasogenic edema. SLEs not necessarily are associated with seizures or epileptiform discharges on electroencephalography.
We agree that double-blind placebo-controlled trials for treatments of SLEs are lacking, but it has to be stressed that some patients with SLEs benefit from anti-seizure drugs, NO-precursors, antioxidants, steroids, or even the ketogenic diet. Whether the application of antiseizure drugs in the absence of seizures or epileptiform discharges is justufied during a SLE, remains speculative, but as long as the epileptogenic hypothesis explaining the pathogenesis of SLEs is unproven, aggressive anti-epileptic treatment does not seem to be justified in this indication.
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